Catalyst
Slingshot members are tracking this event:
Aduro Biotech (ADRO) to launch Anti-APRIL treatment for tumor growth and immune suppression in multiple myeloma, with Phase 1 trial set to begin in 2017
- Source Link:
- https://seekingalpha.com/filing/3351398
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2018
Occurred Source:
http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2335736
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Anti-april, Tumor Growth, Phase 1, Multiple Myeloma
